Menopause Therapeutics: Key Topics for Exam Success
1. perimenopausal onset of menstrual irregularity
2. perimenopausal FSH •FSH >10-12 IU/L on first 2-3 days of menstrual cycle
3. menopause •12 consecutive months of amenorrhea
1/
12
, Menopause Therapeutics: Key Topics for Exam Success
4. menopause FSH •FSH >40 IU/L; ovaries have ceased function
5. do females who had a hys- • Females who have had a hysterectomy (removal of uterus)
terectomy have symptoms of may or may not have symptoms of menopause
menopause?
6. vasomotor symptoms •Hot flashes, night sweats, sleep disturbances, mood
changes
7. Vulvovaginal Atrophy (VVA)/Gen- • Vulvovaginal dryness, irritation or itching, vaginal dis-
itourinary Symptoms of charge
Menopause (GSM) • Dyspareunia: diflcult or painful intercourse
• Urinary symptoms of urgency, dysuria or recurrent UTIs
8. goals of therapy •Decrease symptoms or severity of symptoms
• Improve quality of life
• Address modifiable risk factors
9. decrease symptoms or severity • Continue treatment for at least one month to assess treat-
of symptoms ment ettect
• Side ettects leading to discontinuation?premenstrual like
symptoms; vaginal bleeding
10. address modifiable risk factors smoking, BMI, alcohol use, diet
11. MHT, HT, HRT •MHT = Menopausal hormone therapy
- Preferred broad term used to describe estrogen therapy
or estrogen + progestin therapy
2/
12
1. perimenopausal onset of menstrual irregularity
2. perimenopausal FSH •FSH >10-12 IU/L on first 2-3 days of menstrual cycle
3. menopause •12 consecutive months of amenorrhea
1/
12
, Menopause Therapeutics: Key Topics for Exam Success
4. menopause FSH •FSH >40 IU/L; ovaries have ceased function
5. do females who had a hys- • Females who have had a hysterectomy (removal of uterus)
terectomy have symptoms of may or may not have symptoms of menopause
menopause?
6. vasomotor symptoms •Hot flashes, night sweats, sleep disturbances, mood
changes
7. Vulvovaginal Atrophy (VVA)/Gen- • Vulvovaginal dryness, irritation or itching, vaginal dis-
itourinary Symptoms of charge
Menopause (GSM) • Dyspareunia: diflcult or painful intercourse
• Urinary symptoms of urgency, dysuria or recurrent UTIs
8. goals of therapy •Decrease symptoms or severity of symptoms
• Improve quality of life
• Address modifiable risk factors
9. decrease symptoms or severity • Continue treatment for at least one month to assess treat-
of symptoms ment ettect
• Side ettects leading to discontinuation?premenstrual like
symptoms; vaginal bleeding
10. address modifiable risk factors smoking, BMI, alcohol use, diet
11. MHT, HT, HRT •MHT = Menopausal hormone therapy
- Preferred broad term used to describe estrogen therapy
or estrogen + progestin therapy
2/
12
